Home › Pulmonary Fibrosis › NCT06751069
Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung Disease
Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung Disease: A Prospective Pragmatic Randomized Waitlist-Controlled Trial
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
IInclusion Criteria: * F-ILD diagnosis, any disease subtype, active or prior medical treatment * \>10% fibrosis on CT imaging * mMRC dyspnea score \>1 * All racial or ethnic categories, including non-English speakers (professional translators will be engaged to support screening, enrollment, and study participation) Exclusion Criteria: * Inability to walk (orthopedic/neurologic/cardiac limitation causing immobility) * Cognitive impairment or inability to understand and follow instructions * Traditional center-based PR completed within 3 months of initial study recruitment * Transition to hospice or end-of-life care at the time of screening * Acute exacerbation at the time of screening
About the study
The purpose of this clinical trial is to determine the impact of a home-based pulmonary rehabilitation program with health coaching on patient-reported respiratory-related quality of life and physical activity, as compared to usual care in patients with fibrotic interstitial lung disease.
What is being tested
- Home-based Pulmonary Rehab (behavioral)
Sponsor: Mayo Clinic · Participants: 460 · Started: Mar 3, 2025
Contact the study team
- Johanna Hoult, MS · Phone: 507-293-1989
Official record on ClinicalTrials.gov — NCT06751069
Locations in the U.S.
| Arizona | Mayo Clinic in Arizona, Scottsdale |
| Florida | Mayo Clinic in Florida, Jacksonville |
| Minnesota | University of Minnesota, Minneapolis Mayo Clinic in Rochester, Rochester |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.